WSU LECTURER EARNS NRF RATING FOR TACKLING HEALTH ISSUES IN AFRICA

Senior lecturer at WSU’s Department of Human Biology, Doctor Samuel Olojede obtained a Y2 National Research Foundation (NRF) rating in July, making him one of the youngest researchers in the Faculty of Medicine and Health Sciences to receive the rating.

Olojede’s specialisation is in Clinical Anatomy, with a strong focus on reproductive health, neuroendocrinology and nanomedicine, which is the study of how nanoscale technologies help understand and modulate hormonal signals, enabling precise treatments and personalized care for reproductive, neuroendocrine, and metabolic disorders.  

Awarded to young researchers with a growing national and international research footprint, Olojede’s Y2 rating is evidence of his scholarly contributions to scientific knowledge and solving public health issues.

“For me, this rating is both an honour and a responsibility because it reinforces the importance of continuing impactful research and reflects the strides I have made. For Walter Sisulu University, a great citadel of learning that has given me a platform, this rating enhances the university’s research profile and supports its strategic goal of being a leader in community oriented and health focused innovation,” remarked the scholar.

Instrumental to his recognition was Olojede’s work in using inorganic-based nanoparticles to help medicine reach protected parts of the body, such as the brain and reproductive organs, to effectively treat diseases that affect these parts.

Some of Olojede’s best work has been published in national and international Journals such as Life Sciences Journal, Scientific Reports, Frontiers in Pharmacology, IBRO reports, and Artificial Cells, Nanomedicine, and Biotechnology.

“My research on the Clinical anatomy, toxicological and sex-specific effects of nanotherapeutics, as well as studies exploring the interface between HIV, reproductive outcomes, and metabolic health, have drawn increasing attention from both national and international academic communities,” Olojede added.

As South Africa and the rest of the African continent continue to grapple with chronic illnesses such as HIV and diabetes, Olojede has made strides in producing research which may potentially reduce their effects, such as testicular injury, neurocognitive dysfunction and metabolic complications.

“Overall, the findings support the promising role of novel nanomaterials and drug delivery systems in advancing the treatment of HIV/AIDS and its related complications,” he said.

Through these invaluable contributions, Olojede and WSU continue to push forward the United Nations’ Sustainable Development Goal 3 (SGD3), which advocates for good health and wellbeing.

“My research aims to bridge the gap between basic science and clinical application, particularly in underserved populations,” Olojede declared.

He added, “Ultimately, I hope my work contributes to more equitable health solutions and supports the global agenda for Universal Health Coverage and Sustainable Development Goals, especially in low- and middle-income countries.”

Despite facing resource constraints such as limited funding, and navigating procedural systems that sometimes slow research progress, Olojede remains steadfast in pursuing research excellence.

“I actively seek local and international partnerships, engage in grant writing, and advocate for infrastructure development. Importantly, I focus on producing research that is not only scientifically rigorous but also contextually relevant, ensuring that our work remains impactful despite systemic limitations,” said Olojede.

By Yanga Ziwele